Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Thompson Jeffery S, Director. Officer active across 2 companies, notably Anika Therapeutics, Inc.. Cumulatively, 5 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €45k. Activity tracked since 16 June 2021. The latest transaction was disclosed on 14 June 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Jeffery S Thompson is a Board Member at Anika Therapeutics, Inc. He contributes to the governance of the company by bringing his expertise and experience to the board. His role is crucial in guiding strategic decisions and ensuring the smooth operation of the company.